Amid the declining clinical severity of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and diminishing public uptake of annual coronavirus disease 2019 (Covid-19) vaccines, ...
The Comirnaty 2025-2026 vaccine formulation targets the SARS-CoV-2 sublineage LP.8.1, a descendant of JN.1. The Food and Drug Administration (FDA) has approved Comirnaty ® (LP.8.1-adapted monovalent ...
Co-infection of influenza virus and SARS-CoV-2 can lead to more severe disease than infection of either alone.
CAMBRIDGE, MA / ACCESS Newswire / August 22, 2025 / Moderna announced today that Health Canada has authorized its updated COVID-19 mRNA vaccine, Spikevax®, targeting the SARS-CoV-2 LP.8.1 variant, for ...
Morning Overview on MSN
Scientists are about to unleash the 1st ever universal vaccine
Stanford Medicine researchers reported this week that an intranasal vaccine formula protected mice against a striking range ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results